These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21782133)

  • 41. Progressive renal and cardiovascular disease: optimal treatment strategies.
    Weir MR
    Kidney Int; 2002 Oct; 62(4):1482-92. PubMed ID: 12234333
    [No Abstract]   [Full Text] [Related]  

  • 42. Proteinuria: not a small problem in the little ones.
    Schaefer F
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):696-7. PubMed ID: 19339420
    [No Abstract]   [Full Text] [Related]  

  • 43. Is there any reason to lower proteinuria in a child with nephrotic-range proteinuria who is not clinically edematous?
    Kees-Folts D
    Pediatr Nephrol; 1996 Apr; 10(2):180. PubMed ID: 8703706
    [No Abstract]   [Full Text] [Related]  

  • 44. Novel concepts in understanding and management of glomerular proteinuria.
    Reiser J; von Gersdorff G; Simons M; Schwarz K; Faul C; Giardino L; Heider T; Loos M; Mundel P
    Nephrol Dial Transplant; 2002 Jun; 17(6):951-5. PubMed ID: 12032178
    [No Abstract]   [Full Text] [Related]  

  • 45. Review of recent literature: Existing kidney disease classification guideline needs to incorporate degree of proteinuria with estimated glomerular filtration rate to more accurately predict cardiovascular and renal risk.
    Bloch MJ; Basile JN
    J Clin Hypertens (Greenwich); 2010 Aug; 12(8):627-30. PubMed ID: 20695941
    [No Abstract]   [Full Text] [Related]  

  • 46. Nephropathic nature of proteinuria.
    Remuzzi G
    Curr Opin Nephrol Hypertens; 1999 Nov; 8(6):655-63. PubMed ID: 10630809
    [No Abstract]   [Full Text] [Related]  

  • 47. [Nephrologic problems in pregnancy].
    Kuczyńska-Sicińska J
    Pol Arch Med Wewn; 1973 Feb; 50(2):221-6. PubMed ID: 4691769
    [No Abstract]   [Full Text] [Related]  

  • 48. [Role of the kidneys in the development of acidosis in pregnant women with nephropathy].
    Golota VIa; Kutas VK
    Akush Ginekol (Mosk); 1981 Aug; (8):28-31. PubMed ID: 7316067
    [No Abstract]   [Full Text] [Related]  

  • 49. [Osmoregulatory function of the kidneys in pregnant women with nephropathies].
    Dikusarov VV
    Akush Ginekol (Mosk); 1983 Dec; (12):13-5. PubMed ID: 6666811
    [No Abstract]   [Full Text] [Related]  

  • 50. Results of a prospective study of toxemia of pregnancy.
    Riedel H; Bahlmann J; Eisenbach GM
    Contrib Nephrol; 1981; 25():137-44. PubMed ID: 7226824
    [No Abstract]   [Full Text] [Related]  

  • 51. [Blood circulation parameters in nephropathy in pregnancy].
    Voronin EI; Voronina OIu
    Akush Ginekol (Mosk); 1986 Apr; (4):42-5. PubMed ID: 2940919
    [No Abstract]   [Full Text] [Related]  

  • 52. [Changes in the EEG of pregnant women with nephropathy].
    Palinka GK; Tsitseroshin MN
    Akush Ginekol (Mosk); 1987 Feb; (2):37-40. PubMed ID: 3578686
    [No Abstract]   [Full Text] [Related]  

  • 53. Is the LPS-mediated proteinuria mouse model relevant to human kidney disease?
    Comper WD
    Nat Med; 2009 Feb; 15(2):133; author reply 133-4. PubMed ID: 19197281
    [No Abstract]   [Full Text] [Related]  

  • 54. Glomerular filtration rate in children with chronic kidney disease.
    Harmon WE
    Clin Chem; 2009 Mar; 55(3):400-1. PubMed ID: 19168547
    [No Abstract]   [Full Text] [Related]  

  • 55. [Glomerular proteinuria--new pathogenetic aspects].
    Kokot F; Ficek R
    Pol Arch Med Wewn; 2003 Nov; 110(5):1379-86. PubMed ID: 16737011
    [No Abstract]   [Full Text] [Related]  

  • 56. Proteinuria as a risk factor for the progression of chronic renal disease.
    Petrović D; Stojimirović B
    Vojnosanit Pregl; 2008 Jul; 65(7):552-8. PubMed ID: 18700466
    [No Abstract]   [Full Text] [Related]  

  • 57. The burden of hypertension and kidney disease in Northeast India: the Institute for Indian Mother and Child noncommunicable diseases project.
    Gallieni M; Aiello A; Tucci B; Sala V; Brahmochary Mandal SK; Doneda A; Genovesi S
    ScientificWorldJournal; 2014; 2014():320869. PubMed ID: 24616621
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surrogate end points for clinical trials of kidney disease progression.
    Stevens LA; Greene T; Levey AS
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):874-84. PubMed ID: 17699300
    [No Abstract]   [Full Text] [Related]  

  • 59. Pediatrics: Extracellular volume in children with chronic kidney disease.
    Lemley KV
    Nat Rev Nephrol; 2011 May; 7(7):366-8. PubMed ID: 21610678
    [No Abstract]   [Full Text] [Related]  

  • 60. Chronic kidney disease: Proteinuria as a predictor of rapid eGFR decline.
    Iseki K
    Nat Rev Nephrol; 2013 Oct; 9(10):570-1. PubMed ID: 24018410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.